- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 501/57 - 7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with a further substituent in position 7, e.g. cephamycines
Patent holdings for IPC class C07D 501/57
Total number of patents in this class: 11
10-year publication summary
|
1
|
1
|
2
|
2
|
1
|
0
|
1
|
0
|
0
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Geneheal Biotechnology Co., Ltd. | 31 |
3 |
| The Board of Trustees of the Leland Stanford Junior University | 6296 |
2 |
| KBP Biosciences Co., Ltd. | 29 |
1 |
| The Texas a & M University System | 1646 |
1 |
| CHA University Industry-Academic Cooperation Foundation | 134 |
1 |
| Qilu Anti Pharmaceutical Co. Ltd. | 1 |
1 |
| China Union Chempharma (Suzhou) Co., Ltd. | 1 |
1 |
| The Third Suzhou Pharmaceutical Laboratory | 1 |
1 |
| Other owners | 0 |